Abstract
Obesity has become a worldwide public health problem of epidemic proportions, as it may decrease life expectancy by 7 years at the age of 40 years: excess bodyweight is now the sixth most important risk factor contributing to the overall burden of disease worldwide. Overweight and obesity may increase the risk of erectile dysfunction (ED) by 30–90% as compared with normal weight subjects. On the other hand, subjects with ED tend to be heavier and with a greater waist than subjects without ED, and also are more likely to be hypertensive and hypercholesterolemic. The metabolic syndrome, characterized by a clustering of risk factors associated with insulin resistance and abdominal obesity, associates with ED. Moreover, women with the metabolic syndrome have an increased prevalence of sexual dysfunctions as compared with matched control women. Lifestyle changes aimed at reducing body weight and increasing physical activity induce amelioration of both erectile and endothelial functions in obese men. Moreover, preliminary evidence suggests that a Mediterranean-style diet might be effective in ameliorating sexual function in women with the metabolic syndrome. Lifestyle changes, mainly focussing on regular physical activity and a healthy diet, are effective and safe ways to reduce cardiovascular diseases and premature mortality in all population groups; they may also prevent and treat sexual dysfunctions in both sexes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Flegal KM, Carroll MD, Ogden CL, Johnson CL . Prevalence and trend in obesity among US adults, 1999–2000. JAMA 2002; 288: 1723–1727.
WHO. Obesity: preventing and managing the global epidemic. WHO Technical Report Series Number 894. WHO: Geneva, 2000.
James WTP, Rigby N, Leach R . The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11: 3–8.
Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Nonneux L . NEDCOM, the Netherlands epidemiology and demographic compression on morbidity research group. obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138: 24–32.
Preston HP . Deadweight? The influence of obesity on longevity. N Engl J Med 2005; 352: 1135–1137.
Williamson DF, Parnuk E, Thues M, Flanders D, Byers T, Heath C . Modest intentional weight loss increases life expectancy in overweight women. Am J Epidemiol 1995; 141: 1128–1145.
Lean ME, Powrie JK, Anderson AS, Garthwaite PH . Obesity, weight loss and prognosis of type 2 diabetes. Diabet Med 1990; 7: 228–233.
Kopelman PG . Obesity as a medical problem. Nature 2000; 404: 635–643.
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ . Comparative risk assessment collaborative group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–1360.
Wolf HK, Tuomilehto J, Kuulasmaa K, Domarkiene S, Cepaitis Z, Molarius A et al. Blood pressure levels in the 41 populations of the WHO MONICA project. J Hum Hypertens 1997; 11: 733–742.
Kastarinen MJ, Nissinen AM, Vartiainen EA, Jousilahti PJ, Korhonen HJ, Puska PM et al. Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. J Hypertens 2000; 18: 255–262.
Appel LJ, Moore TG, Obarzanek R, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. A clinical trial of effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 117–124.
Wannamethee SG, Shaper AG, Durrington PN, Perry IJ . Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998; 12: 735–741.
Hu FB, Manson JE, Stampfer MJ, Colditz J, Liu S, Solomon CG et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790–797.
Hu G, Lindstrom J, Valle TT, Eriksson GJ, Jousilahti P, Silventoinen K et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 2004; 164: 892–896.
Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB . Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003; 139: 161–168.
Pinnock CB, Stapleton AM, Marshall VR . Erectile dysfunction in the community: a prevalence study. Med J Aust 1999; 171: 353–357.
Chung WS, Sohn JH, Park YY . Is obesity an underlying factor in erectile dysfunction? Eur Urol 1999; 36: 68–70.
Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo . Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328–338.
Fung MM, Bettencourt R, Barrett-Connor H . Heart disease risk factors predict erectile dysfunction 25 years later. J Am Coll Cardiol 2004; 43: 1405–1411.
Esposito K, Giugliano F, De Sio M, Carleo D, Di Palo C, D'Armineto M et al. Dietary factors in erectile dysfunction. Int J Impot Res 2006; 18: 370–374.
Esposito K, Giugliano D . The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004; 14: 228–232.
Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799–1804.
Bonetti PO, Lerman LO, Lerman A . Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168–175.
Cheitlin MD . Erectile dysfunction. The earliest sign of generalized vascular disease? J Am Coll Cardiol 2004; 43: 185–186.
Blumentals WA, Gomez-Caminero A, Joo S, Vannapagari V . Should erectile dysfunction be considered as a marker for acute myocardial infarction? Int J Imp Res 2004; 16: 350–353.
Giugliano F, Esposito K, Di Palo C, Ciotola M, Giugliano G, Marfella R et al. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokines levels in obese men. J Endocrinol Invest 2004; 27: 665–669.
Diamant M, Tushuizen ME, Sturk A, Nieuwland R . Cellular microparticles: new players in the field of vascular disease. Eur J Clin Invest 2004; 34: 392–401.
Ferreira AC, Peter AA, Mendez AJ, Jiemenez JJ, Mauro LM, Chirinos JA et al. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation 2004; 110: 3599–3603.
Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51: 2840–2845.
Bernal-Mizrachi L, Jy W, Fierro C, Macdonough R, Velazques HA, Purow J et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute syndrome. Int J Cardiol 2004; 97: 439–446.
Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T et al. Elevated levels of VE-Cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45: 1622–1630.
Werner N, Wassmann S, Ahlers P, Kosiol S, Nickening G . Circulating CD31+/Annessin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 112–116.
Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649–2652.
Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS . Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Circ Heart Physiol 2004; 286: H1910–H1915.
Mesri M, Altieri DC . Leukocyte microparticles stimulate endothelial cells cytokine release and tissue factor induction in JNK-1 signaling pathway. J Biol Chem 1999; 274: 23111–23118.
Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR et al. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2007; 19: 161–166.
Ford ES, Giles WH, Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.
Ford ES . Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745–2749.
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486–2497.
Esposito K, Giugliano F, Martedì E, Feola G, Marfella R, D'Armiento M et al. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care 2005; 28: 1201–1203.
Bansal TC, Guay AT, Jacobson J, Woods BO, Nesto RW . Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med 2005; 2: 96–103.
Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006; 50: 595–604.
Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP et al. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 2005; 90: 712–719.
Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB . Low sex hormone-binding globulin, total testosterone, and symptomatic androgen defi ciency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 2006; 91: 843–850.
Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgendeprivation therapy. J Clin Oncol 2006; 24: 3979–3983.
Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA . Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002; 87: 3632–3639.
Billups KL . Sexual dysfunction and cardiovascular disease: integrative concepts and strategies. Am J Cardiol 2005; 96: 57–61.
Kaplan SA, Meehan AG, Shah A . The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 2006; 176 (4 Part 1): 1524–1527.
Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J et al. Report of international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888–893.
Edwards WM, Coleman E . Defining sexual health: a descriptive overview. Arch Sex Behav 2004; 33: 189–195.
Frank E, Anderson C, Rubinstein D . Frequency of sexual dysfunction in normal couples. N Engl J Med 1978; 299: 111–115.
Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–544.
Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E et al. Sexual problems amomg women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Intern J Impot Res 2005; 17: 39–57.
Esposito K, Giugliano D . Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005; 17: 391–398.
Kirchengast S, Hartmann B, Gruber D, Huber J . Decreased sexual interest and its relationship to body build in postmenopausal women. Maturitas 1996; 23: 63–71.
Brody S . Slimness is associated with greater intercourse and lesser masturbation frequency. J Sex Marital Ther 2004; 30: 251–261.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsign R et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marit Ther 2000; 26: 191–208.
Corona G, Jannini EA, Maggi M . Inventories for male and female sexual dysfunction. Int J Impot Res 2006; 18: 236–250.
Corona G, Mannucci E, Mansani R, Petrone L, Bartolini M, Giommi R et al. Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol 2004; 46: 222–228.
Enzlin P, Mathieu C, Van den Bruel A, Bosteels J, Vanderschueren D, Demyttenaere K . Sexual dysfunction in women with type 1 diabetes. Diabetes Care 2002; 25: 672–677.
Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA . Diabetic neuropathy: an intensive review. Am J Health Syst Pharm 2004; 61: 160–173.
Salonia A, Lanzi R, Scavini M, Postillo M, Gatti E, Putrella G et al. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 2006; 29: 312–316.
Esposito K, Ciotola M, Giugliano F, Bisogni C, Schisano B, Autorino R et al. Association of body weight with sexual function in women. Int J Impot Res 2007; 19: 353–357.
Basson R . Women's sexual dysfunction: revised and expanded definitions. CMAJ 2005; 172: 1327–1333.
Esposito K, Giugliano G, Scuderi N, Giugliano D . Role of adipokines in the obesity-inflammation relationship: the effect of fat removal. Plast Reconstr Surg 2006; 118: 1048–1057.
Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D . The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res 2005; 17: 224–226.
Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB . Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.
Cheng JYW, Ng EML, Chen RYL . Physical activity and erectile dysfunction: meta-analysis of population-based studies. Int J Impot Res 2007; 19: 245–252.
Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized trial. JAMA 2004; 291: 2978–2984.
Willett WC, Dietz WH, Colditz GA . Guidelines for healthy weight. N Engl J Med 1999; 341: 427–434.
Katzmarzyk PT, Janssen I, Ardem CI . Physical inactivity, excess adiposity and premature mortality. Obes Rev 2003; 4: 257–271.
Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P . The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes Relat Metab Disord 2005; 29: 894–902.
Fung TT, Schulze M, Manson JE, Willett WC, Hu FB . Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med 2004; 164: 2235–2240.
Montonen J, Knekt P, Harkanen T, Jarvinen R, Heliovaara M, Aromaa A et al. Dietary patterns and the incidence of type 2 diabetes. Am J Epidemiol 2005; 161: 219–227.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Esposito, K., Giugliano, F., Ciotola, M. et al. Obesity and sexual dysfunction, male and female. Int J Impot Res 20, 358–365 (2008). https://doi.org/10.1038/ijir.2008.9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2008.9